Drug Database
L04AX05 pirfenidone
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Esbriet 267 mg Hard Capsules
- POM Esbriet 267 mg, 534 mg, 801 mg Film-coated Tablets
- POM Pirfenidone 267 mg film-coated tablets
- POM Pirfenidone 267 mg film-coated tablets
- POM Pirfenidone 267 mg film-coated tablets
- POM Pirfenidone 267 mg film-coated tablets
- POM Pirfenidone 267 mg film-coated tablets
- POM Pirfenidone 267 mg Film-coated Tablets
- POM Pirfenidone 267 mg Film-Coated Tablets
- POM Pirfenidone 267mg Film-coated Tablets
- POM Pirfenidone 267mg Film-Coated Tablets
- POM Pirfenidone 534 mg film-coated tablets
- POM Pirfenidone 534 mg film-coated tablets
- POM Pirfenidone 534 mg Film-Coated Tablets
- POM Pirfenidone 801 mg film-coated tablets
- POM Pirfenidone 801 mg film-coated tablets
- POM Pirfenidone 801 mg film-coated tablets
- POM Pirfenidone 801 mg film-coated tablets
- POM Pirfenidone 801 mg film-coated tablets
- POM Pirfenidone 801 mg Film-coated Tablets
- POM Pirfenidone 801 mg Film-Coated Tablets
- POM Pirfenidone 801mg Film-coated Tablets
- POM Pirfenidone 801mg Film-Coated Tablets
- POM Pirfenidone Lupin 267 mg film-coated tablets
- POM Pirfenidone Lupin 801 mg film-coated tablets
- POM Pirfenidone Sandoz 267 mg film-coated tablets
- POM Pirfenidone Sandoz 801 mg film-coated tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).